Literature DB >> 9661992

Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s.

N C Berchtold1, C W Cotman.   

Abstract

Most histories of senile dementia commence with Alois Alzheimer's description in 1906 of the first case of Alzheimer's disease, yet the history of senile dementia before 1906 is quite rich, dating back to the ancient Greek and Roman philosophers and physicians. Over the 2500 years since ancient times, the concept of senile dementia has evolved from a rather vague notion that mental decline occurred inevitably in old age, to become defined today by a distinct set of clinical and pathological features with the potential for treatment and prevention within grasp. Throughout history, many elderly individuals with unpredictable behavior were sequestered in institutions, and the line between mental disorders and senile dementia was hazy at best. The identification of Alzheimer's disease at the onset of the 20th century was a turning point for the understanding of senile dementia, and the concepts and histological findings presented by the early researchers of Alzheimer's disease remain relevant still today. Indeed, these early findings are proving to be a continuing source of insight, as many of the issues debated at the turn of the century remain unresolved still today. This paper thus traces the history of the evolution of our current conceptualization of Alzheimer's disease from the amorphous Greco-Roman concept of age-associated dementia.

Entities:  

Mesh:

Year:  1998        PMID: 9661992     DOI: 10.1016/s0197-4580(98)00052-9

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  74 in total

1.  Discriminative multi-task feature selection for multi-modality classification of Alzheimer's disease.

Authors:  Tingting Ye; Chen Zu; Biao Jie; Dinggang Shen; Daoqiang Zhang
Journal:  Brain Imaging Behav       Date:  2016-09       Impact factor: 3.978

Review 2.  Single cell gene expression profiling in Alzheimer's disease.

Authors:  Stephen D Ginsberg; Shaoli Che; Scott E Counts; Elliott J Mufson
Journal:  NeuroRx       Date:  2006-07

3.  Where vascular meets neurodegenerative disease.

Authors:  Julie A Schneider; David A Bennett
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

Review 4.  The role of environmental exposures in neurodegeneration and neurodegenerative diseases.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Toxicol Sci       Date:  2011-09-13       Impact factor: 4.849

Review 5.  Herbal medicine in the treatment of Alzheimer's disease.

Authors:  Jian-guo Wu; Yan-yan Wang; Zi-lv Zhang; Bin Yu
Journal:  Chin J Integr Med       Date:  2014-04-22       Impact factor: 1.978

Review 6.  Cortical excitability and neurology: insights into the pathophysiology.

Authors:  Radwa A B Badawy; Tobias Loetscher; Richard A L Macdonell; Amy Brodtmann
Journal:  Funct Neurol       Date:  2012 Jul-Sep

Review 7.  Senescent-induced dysregulation of cAMP/CREB signaling and correlations with cognitive decline.

Authors:  Rolf T Hansen; Han-Ting Zhang
Journal:  Brain Res       Date:  2013-04-25       Impact factor: 3.252

Review 8.  Tau-induced neurodegeneration: mechanisms and targets.

Authors:  Cindy Beharry; Leah S Cohen; Jing Di; Kawsar Ibrahim; Susan Briffa-Mirabella; Alejandra del C Alonso
Journal:  Neurosci Bull       Date:  2014-04-15       Impact factor: 5.203

9.  Frequent and discriminative subnetwork mining for mild cognitive impairment classification.

Authors:  Fei Fei; Biao Jie; Daoqiang Zhang
Journal:  Brain Connect       Date:  2014-06

Review 10.  Alzheimer disease immunotherapeutics: then and now.

Authors:  Harashish Jindal; Bhumika Bhatt; Shashikantha Sk; Jagbir Singh Malik
Journal:  Hum Vaccin Immunother       Date:  2014-10-31       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.